SCHEMBL6469014

SCHEMBL6469014

Cc1nc(Nc2nc(O)c3ccccc3n2)nc2cc3c(cc12)OCO3

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.65
KDM4E B2RXH2 6/20 0.65
HSD17B10 Q99714 6/20 0.65
HPGD P15428 4/20 0.65
SMN1; SMN2 Q16637 5/20 0.61
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
MAPT P10636 4/20 0.51
LMNA P02545 3/20 0.49
PKM P14618 1/20 0.49
ADORA2A P29274 1/20 0.49
ADORA1 P30542 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.41
MAPK1 P28482 5/20 0.41
TSHR P16473 5/20 0.41
TP53 P04637 4/20 0.41
HTT P42858 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL119513 0.80 ALDH1A1 (0.61) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL6470228 0.80 KMT2A (0.49) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL7056715 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL6470113 0.78 MAPT (0.51) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
Trifluoroacetic Acid SCHEMBL6471213 0.78 KMT2A (0.44) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL22834199 0.78 KMT2A (0.50) ALDH1A1KDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL6470146 0.76 MAPT (0.61) ALDH1A1KDM4EHPGDSMN1; SMN2NPC1
Trifluoroacetic Acid SCHEMBL6470605 0.74 HPGD (0.44) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL6465726 0.70 KMT2A (0.50) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6467878 0.69 KMT2A (0.47) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB ALDH1A1 3154/4885KDM4E 3225/4885HSD17B10 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.